Rita De Santis. (2020). Anti-ErbB2 immunotherapeutics: Struggling to make better antibodies for cancer therapy. Taylor & Francis Group.
Chicago Style (17th ed.) CitationRita De Santis. Anti-ErbB2 Immunotherapeutics: Struggling to Make Better Antibodies for Cancer Therapy. Taylor & Francis Group, 2020.
MLA (9th ed.) CitationRita De Santis. Anti-ErbB2 Immunotherapeutics: Struggling to Make Better Antibodies for Cancer Therapy. Taylor & Francis Group, 2020.
Warning: These citations may not always be 100% accurate.